1.Recent advance in stem cell transplantation in treatment of traumatic brain injury
Ji ZHANG ; Xiaojun ZHANG ; Xuheng JIANG ; Xiaofei HUANG ; Fangke XIE ; Sijia LIU ; Tianjing SUN ; Hongfei GE ; Anyong YU
Chinese Journal of Neuromedicine 2019;18(6):634-638
Traumatic brain injury (TBI) is one of the diseases with high morbidity,mortality,and disability,which seriously endangers human health.Primary and secondary injuries caused by TBI are cascade reaction of various pathophysiological interactions.Because of its many injury factors and complex mechanisms,the treatment and therapeutic effect of TBI are limited at present.In recent years,animal experiments and clinical studies have shown that stem cell therapy could alleviate TBI-mediated neurological damage to a certain extent.Therefore,activation of endogenous neural cells response and transplantation of exogenous stem cells may be new strategies for TBI treatment.This article reviews the research progress of activation of endogenous neural cells response and transplantation of exogenous stem cells after TBI,and focuses on the therapeutic effects and possible mechanisms of stem cell transplantation in TBI treatment.
2.Current status of spleen-mediated inflammatory response in traumatic acute respiratory distress syndrome
Sijia LIU ; Tianxi ZHANG ; Tianjing SUN ; Fangke XIE ; Xuheng JIANG ; Xiaofei HUANG ; Ji ZHANG ; Xiaojun ZHANG ; Anyong YU
Chinese Critical Care Medicine 2019;31(5):654-657
Acute respiratory distress syndrome (ARDS) is considered to be a pulmonary manifestation of systemic inflammatory response syndrome (SIRS), often occurring as a complication of disease, and worsening the prognosis of patients. In recent years, the incidence of trauma has increased year by year. Severe trauma can lead to SIRS, which is one of the common risk factors of ARDS. The spleen is the largest peripheral immune organ of the body, containing a large number of immune cells and secreting inflammatory factors. The inflammatory factors play an important role in the formation of traumatic ARDS. In recent years, the benefits of treating ARDS by inhibiting spleen-induced inflammatory response have gradually been discovered, providing new ideas for the treatment of ARDS. Therefore, the research status of spleen-mediated inflammatory response in traumatic ARDS is of great significance for the prevention and treatment of traumatic ARDS. This article reports the spleen-mediated systemic inflammatory response, the role of inflammatory mediators in the development of ARDS, and the current state of research on ARDS treatment to explore new approaches to the prevention and treatment of traumatic ARDS.